[{"AccountsPayableCurrent_0_Q1_USD":4274000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":381000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3456000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":4209000.0,"ShortTermInvestments_0_Q1_USD":97870000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":106546000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":207000.0,"DividendsCommonStockCash_1_Q1_USD":0.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2414000.0,"PaymentsOfDividendsPreferredStockAndPreferenceStock_1_Q1_USD":0.0,"InvestmentIncomeInterest_1_Q1_USD":789000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-1038000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":5410000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":207000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-26212000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":718000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-7061000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":228000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":4209000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":204206000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":59408000.0,"PurchaseCommitmentRemainingMinimumAmountCommitted_0_Q1_USD":1508000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_1_Q1_USD":115200000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":26187000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0716,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1629000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":551000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1689000.0,"OperatingLeaseLiability_0_Q1_USD":2240000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_1_Q1_USD":0.0,"OperatingLeaseCost_1_Q1_USD":340000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1366000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":972000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":2338000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":55000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q1_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"DividendsPreferredStockCash_1_Q1_USD":0.0,"CashCollateralForBorrowedSecurities_0_Q1_USD":210000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":98000.0,"DeferredTaxAssetsValuationAllowance_0_Q1_USD":5410000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":726000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":8723000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":88790000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2414000.0,"LiabilitiesCurrent_0_Q1_USD":19342000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":226108000.0,"Liabilities_0_Q1_USD":20274000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":598000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1197000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-2179000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-31796000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-28598000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.48,"Depreciation_1_Q1_USD":594000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":106336000.0,"AssetsCurrent_0_Q1_USD":213055000.0,"Assets_0_Q1_USD":226108000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":9292915.0,"AdditionalPaidInCapital_0_Q1_USD":588090000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":240000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8486000.0,"RestrictedCashNoncurrent_0_Q1_USD":210000.0,"NetIncomeLoss_1_Q1_USD":-26419000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":8849000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":2919000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2414000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0082,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.7983,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":4209000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":20901000.0,"OperatingLossCarryforwards_0_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":223000.0,"OperatingIncomeLoss_1_Q1_USD":-29387000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":13379000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":55322690.0,"StockholdersEquity_0_Q1_USD":205834000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-382511000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":5804000.0,"ProfitLoss_1_Q1_USD":-26419000.0,"OperatingExpenses_1_Q1_USD":29387000.0,"VariableLeaseCost_1_Q1_USD":50000.0,"Ticker":"KNSA","CIK":"1730430","name":"KINIKSA PHARMACEUTICALS, LTD.","OfficialName":"Kiniksa Pharmaceuticals Ltd. Class A Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"764985918.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200504"}]